AMBER ALLEN: Open Payments
NPI 1437448784 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 33 payments from 10 companies in 2025. Trend: 2023 $381 · 2024 $783 · 2025 $796
Food & beverage: $788Education: $8
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $434 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Ionis Pharmaceuticals, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Organon LLC | 1 | $24 |
| ABIOMED | 1 | $22 |
| Amgen Inc. | 1 | $16 |
Products named: DUPIXENT, FASENRA, NUCALA, Ohtuvayre, AIRSUPRA, CUVITRU, VTAMA, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
